Full-Time

Histotechnologist

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Junior, Mid

Chicago, IL, USA

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Requirements
  • HT or HTL Certification preferred
  • Associates or Bachelor's Degree
  • Familiarity with Leica equipment, manual microtomes, both Leica and Roche automated IHC staining instruments
  • Knowledge of CAP regulations
  • Experience with pathology laboratory SOPs and protocols
  • Comfort with laboratory safety and training
  • Demonstrates problem solving skills in the laboratory
  • Good communication and organization skills
Responsibilities
  • Preparation of both unstained and routine hematoxylin and eosin stained slides from formalin fixed paraffin embedded tissue blocks
  • Maintain laboratory equipment and record maintenance regularly
  • Approach work with safety and diligence and follow safety requirements of the laboratory
  • Perform routine workflows without specific guidance
  • Reliably produce quality finished product
  • Assist in the development of standard operating procedures for new instruments and products
  • Collaborate with other members of the Tempus Labs team
  • Utilize microtome, water bath, automated stainer, automated coverslipper, tissue processors, and embedding centers
  • Collaborate with in-house pathologists for slide quality review
  • Ability to cut frozen sections using a cryostat
  • Track work completed using a custom Laboratory Information Management System (LIMS)
  • Work collaboratively with other members of the Histology team to accomplish daily cutting and staining deadlines

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data to assist physicians in making informed treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights, aiming to improve patient care and support drug development.

Company Stage

IPO

Total Funding

$894.9M

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

5%

1 year growth

14%

2 year growth

35%
Simplify Jobs

Simplify's Take

What believers are saying

  • Integration with Flatiron's OncoEMR enhances genomic data accessibility for oncologists.
  • Acquisition of Ambry Genetics expands Tempus's capabilities in medical diagnostics and testing.
  • Collaboration with BioNTech leverages real-world data for enhanced drug development.

What critics are saying

  • Ambry Genetics acquisition may strain financial resources and impact operational efficiency.
  • Collaboration with Flatiron Health may face data privacy and interoperability issues.
  • Immune Profile Score algorithmic test may encounter regulatory scrutiny, delaying adoption.

What makes Tempus unique

  • Tempus uses AI to analyze clinical and molecular data for precision medicine.
  • Their platform aids drug development by discovering novel targets and evaluating treatments.
  • Tempus's pan-cancer organoid platform enhances personalized therapeutic opportunities for cancer patients.

Help us improve and share your feedback! Did you find this helpful?